1659 related articles for article (PubMed ID: 18780864)
1. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
2. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
Shen Y; Parmigiani G
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
[TBL] [Abstract][Full Text] [Related]
3. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40-49 years.
Ohnuki K; Kuriyama S; Shoji N; Nishino Y; Tsuji I; Ohuchi N
Cancer Sci; 2006 Nov; 97(11):1242-7. PubMed ID: 16918992
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
6. Economic considerations in breast cancer screening of older women.
Brown ML
J Gerontol; 1992 Nov; 47 Spec No():51-8. PubMed ID: 1430883
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
Feig S
Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
[TBL] [Abstract][Full Text] [Related]
9. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
[TBL] [Abstract][Full Text] [Related]
10. [Cost-effectiveness of mammography screening in Norway].
Kåresen R; Bø JK; Haustveit S; Hervik A; Thoresen SO
Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3553-9. PubMed ID: 10563171
[TBL] [Abstract][Full Text] [Related]
11. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
[TBL] [Abstract][Full Text] [Related]
12. The value of mammography in different ethnic groups in Israel--analysis of mortality reduction and costs using CAN*TROL.
Rennert G
Cancer Detect Prev; 1991; 15(6):477-81. PubMed ID: 1723656
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of cervical-cancer screening in five developing countries.
Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
[TBL] [Abstract][Full Text] [Related]
14. The effect of service screening on breast cancer mortality rates.
Cox B
Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
[TBL] [Abstract][Full Text] [Related]
15. Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography?
Duffy SW; Tabar L; Vitak B; Warwick J
Breast J; 2006; 12 Suppl 1():S91-5. PubMed ID: 16430402
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests.
Kulasingam SL; Myers ER; Lawson HW; McConnell KJ; Kerlikowske K; Melnikow J; Washington AE; Sawaya GF
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):321-8. PubMed ID: 16449119
[TBL] [Abstract][Full Text] [Related]
17. Costs, effects and cost-effectiveness of breast cancer control in Ghana.
Zelle SG; Nyarko KM; Bosu WK; Aikins M; Niëns LM; Lauer JA; Sepulveda CR; Hontelez JA; Baltussen R
Trop Med Int Health; 2012 Aug; 17(8):1031-43. PubMed ID: 22809238
[TBL] [Abstract][Full Text] [Related]
18. The contribution of clinical breast examination to the accuracy of breast screening.
Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
[TBL] [Abstract][Full Text] [Related]
19. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
[TBL] [Abstract][Full Text] [Related]
20. Risk- and cost-benefit analyses of breast screening programs derived from absorbed dose measurements in The Netherlands.
Zuur C; Broerse JJ
Diagn Imaging Clin Med; 1985; 54(3-4):211-22. PubMed ID: 3928229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
